[High dose chemotherapy followed by autologous bone marrow graft in solid tumors in children: arguments for].
Arguments for the use of high-dose chemotherapy followed by autologous bone marrow transplantation in pediatric solid tumors are discussed. The dose effect relationship in pediatric oncology conventional chemotherapy is emphasized. Results of high-dose chemotherapy followed by autologous bone marrow transplantation are encouraging in metastatic neuroblastoma and Ewing's sarcoma. The probability of event free survival is increased of about 30% as compared to that of conventional treatments. This therapeutic approach could be of value in other pediatric solid tumors, particularly in some poor prognosis forms of Wilm's tumors. However, until now, the results remain preliminary. On the other hand, the role of this strategy in chemoresistant tumors, such as malignant gliomas, remains under investigation.
Hartmann
O
O
Département de pédiatrie, Institut Gustave-Roussy, Villejuif, France.
Valteau-Couanet
D
D
Benhamou
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D009447:Neuroblastoma / Q000401:mortality / Q000628:therapy*; D012074:Remission Induction; D012512:Sarcoma, Ewing / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D014182:Transplantation, Autologous
Chimiothérapie à hautes doses suivie d'autogreffe de moelle dans les tumeurs solides de l'enfant: les arguments pour.